Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, 12, 211".

Antonella CasiraghiChiara Grazia GennariUmberto Maria Musazzi Marco Aldo OrtenziSusanna BordignonPaola Minghetti

Published in: Pharmaceutics (2020)

The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].

Keyphrases

drug delivery
chronic rhinosinusitis
combination therapy
replacement therapy